Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Akebia Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 143 | 158 | +15 |
| Shares | 95.5M | 108.3M | +12.8M (+13.4%) |
| Value | $182.7M | $394.1M | +$211.4M (+115.7%) |
New holders (33)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (18)
Institutions that held Akebia Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| AIGH Capital Management LLC | 2,925,000 | $5.62M |
| Monashee Investment Management LLC | 1,500,000 | $2.88M |
| AXA S.A. | 627,892 | $1.21M |
| Maven Securities LTD | 200,000 | $384.0K |
| Exome Asset Management LLC | 189,087 | $363.0K |
| Jane Street Group, LLC | 173,431 | $333.0K |
| Alyeska Investment Group, L.P. | 134,277 | $257.8K |
| Corebridge Financial, Inc. | 106,085 | $203.7K |
| Verition Fund Management LLC | 104,334 | $200.3K |
| SG Americas Securities, LLC | 89,023 | $171.0K |
| Private Advisor Group, LLC | 61,816 | $118.7K |
| State of Wyoming | 59,206 | $113.7K |
| HRT Financial LP | 46,726 | $89.0K |
| Captrust Financial Advisors | 32,663 | $62.7K |
| Unified Investment Management | 17,000 | $32.6K |
| Scientech Research LLC | 10,510 | $20.2K |
| Empirical Asset Management, LLC | 10,000 | $19.2K |
| Northwestern Mutual Wealth Management Co | 5 | $10 |